Kymera Therapeutics, Inc. (KYMR) shares fell 0.1% to $117.67 as of September 22, 2026, a slight decline from the prior close of $117.75. BestStocks flagged the session as a major change for KYMR. The move is tied to price move up. Below, we break down what changed for KYMR, why it matters for investors, how the stock reacted, and the catalysts on the calendar.
What happened
KYMR fell 0.1% to $117.67
KYMR fell 0.1% in its latest session, moving from $117.75 to $117.67.
Material / EarningsWeak confidence
Rel. volume
0.8×
Below Avg
Vs peers
—
No comparable peers
Market cap
$9.7B
NASDAQ Global Market
Analyst target
$137
+16.2% vs price
Price chart
Aug 24 – Sep 22
E earnings
F filing
A analyst
V/N other
click a marker to highlight
Change events — click to jump to details
What it means for Kymera Therapeutics, Inc. investors
For Kymera Therapeutics, Inc. investors, the recent signals add up to a bearish shift. On the constructive side: Positive price momentum. Weighing against that: Material negative event; Negative session, down 0.1%. Wall Street's consensus price target sits at $136.75, implying +16.2% upside from $117.67. Over the past 90 days analysts logged 1 upgrade and 1 downgrade. BestStocks rates the overall signal quality weak (32/100). With earnings roughly 42 days out, the next report is the most likely near-term test of the move.
KYMR price reaction
KYMR last traded at $117.67, down $0.08 (-0.07%) from the previous close of $117.75. The session traded on 0.8× average volume (below avg), so participation was unremarkable. Over the past month the stock has ranged between $113.15 and $126.64, and it currently sits about 34% of the way up that band.
Bullish and bearish analyst opinions on Kymera Therapeutics, Inc. (KYMR)
The consensus analyst price target on Kymera Therapeutics, Inc. (KYMR) is $136.75, 16.2% above the recent $117.67. Over the past 90 days analysts logged 1 upgrade, 11 maintains, and 1 downgrade. Here is how the bullish and bearish cases on KYMR line up.
▲ The bullish case
+Wall Street's consensus price target of $136.75 implies +16.2% upside from $117.67.
+The Street's most bullish target is $180.00 (+53.0%).
+1 analyst upgrade in the past 90 days, most recently Wolfe Research to Outperform (2026-09-10).
+Positive price momentum.
▼ The bearish case
−The most bearish analyst target is $97.00 (-17.6%).
−1 analyst downgrade in the past 90 days, most recently RBC Capital to Sector Perform (2026-07-13).
−Material negative event.
−Negative session, down 0.1%.
−Kymera Therapeutics, Inc. (KYMR) moved −7.50% from $119.35 to $110.40 on 2026-07-13.
Bull vs bear balanceBearish Shift
BearishNeutralBullish
Weighing both sides, BestStocks' composite read of recent signals is bearish, as the bull-versus-bear meter above shows. This is an educational summary of the bull and bear case, not investment advice.
Analyst price targets and ratings are FMP consensus figures as of Sep 22, 2026; other aggregators may differ. High and low targets show the range of estimates, not forecasts.
Kymera Therapeutics, Inc. (KYMR) moved −2.91% from $118.40 to $114.96 on 2026-09-11. We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. Volume remained near its 5-day average.
Material / Earnings2026-09-04+0.1%
Kymera Therapeutics, Inc. (KYMR) moved +4.10% from $112.77 to $117.39 on 2026-09-04. We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. Volume remained near its 5-day average.
Material / Earnings2026-08-27-4.2%
Kymera Therapeutics, Inc. (KYMR) moved −3.81% from $124.99 to $120.23 on 2026-08-27. We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. Volume remained near its 5-day average, suggesting the move was not driven by unusual trading activity.
Material / Earnings2026-08-25+4.6%
Kymera Therapeutics, Inc. (KYMR) moved +3.26% from $122.64 to $126.64 on 2026-08-25. We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found.
Material / Earnings2026-08-21-1.4%
Kymera Therapeutics, Inc. (KYMR) moved -2.50% from $122.87 to $119.80 on 2026-08-21. We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. Volume remained near its 5-day average, suggesting the move was not driven by unusual trading activity.
Material / Earnings2026-08-20-4.6%
Kymera Therapeutics, Inc. (KYMR) moved -2.78% from $124.98 to $121.50 on 2026-08-20. We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. Volume remained near its 5-day average, suggesting the decline occurred without unusual trading interest.
Material / Earnings2026-08-19+4.9%
Kymera Therapeutics, Inc. (KYMR) moved +2.15% from $124.63 to $127.31 on 2026-08-19, reaching a new 30-day high. We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found.
Material / Earnings2026-08-17+3.4%
Kymera Therapeutics, Inc. (KYMR) moved +3.55% from $117.25 to $121.41 on 2026-08-17, reaching a new 30-day high. We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found.
Upcoming catalysts & outlook
Next earnings
2026-11-03 (est.)
in 42 days
10-Q Filing (est.)
2026-11-04
Medium impact
Thesis shift
Bearish Shift
bearish signal
Risk level
Medium
from change events
Frequently asked questions about KYMR
Why did Kymera Therapeutics, Inc. (KYMR) stock move?
KYMR fell 0.1% to $117.67. No single company-specific catalyst was confirmed during the move window, and it looks technical.
How much did KYMR stock fall?
KYMR lost 0.07% ($0.08) versus the prior close of $117.75, last trading at $117.67 on 0.8× average volume.
When is Kymera Therapeutics, Inc.'s next earnings date?
KYMR's next earnings report is estimated for 2026-11-03 — about 42 days away.
What is the analyst price target for KYMR?
The consensus analyst price target for KYMR is $136.75, about 16.2% above the current $117.67. Over the past 90 days, analysts recorded 1 upgrade, 11 maintains, and 1 downgrade.
How BestStocks tracks KYMR
This page is generated automatically by BestStocks' change-detection system after price move up was detected and verified against independent data sources. It draws on 20 tracked change events for KYMR, cross-checked against the data sources listed below. Price, volume, and market-capitalization figures are the live intraday quote as of September 22, 2026 and refresh as new information is detected; for companies with multiple share classes, market-cap figures can differ by data source. Analyst price targets and ratings are FMP consensus. This is an educational summary of what changed and why — not personalized investment advice.
